SHERYL LIST: Open Payments
NPI 1962020875 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 48 payments from 12 companies in 2025. Trend: 2023 $991 · 2024 $1,153 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $212 |
| Noven Therapeutics, LLC | 11 | $175 |
| Alkermes, Inc. | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $64 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
Products named: VRAYLAR, Xelstrym, TRINTELLIX, ARISTADA, REXULTI, HETLIOZ, AUSTEDO XR, LYBALVI.
Industry payments across OH — which companies pay providers there.
